CANBRIDGE PHARM.DL-00001 Net Asset Quality Index
CANBRIDGE PHARM.DL-00001 net asset quality index. CANBRIDGE PHARM.DL-00001 (MF1) has a Net Asset Quality Index of -206.6% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €165.39 Million minus total liabilities of €507.15 Million yields net assets of €-341.75 Million. A higher index indicates a stronger, lower-leverage balance sheet. See MF1 book value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of CANBRIDGE PHARM.DL-00001 (2021–2025)
Net asset quality index of CANBRIDGE PHARM.DL-00001 from 2021 to 2025. This chart shows how CANBRIDGE PHARM.DL-00001's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the index stands at -206.6%, representing net assets of €-341.75 Million against total assets of €165.39 Million EUR. Check CANBRIDGE PHARM.DL-00001 tangible book value ratio to evaluate the tangible quality of the company's equity base.
CANBRIDGE PHARM.DL-00001 Net Asset Quality Index by Year (2021–2025)
CANBRIDGE PHARM.DL-00001 net asset quality index by year from 2021 to 2025. The table below presents the year-by-year Net Asset Quality Index for CANBRIDGE PHARM.DL-00001 from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see MF1 market cap.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -206.6% | €-341.75 Million | €165.39 Million | €507.15 Million | ▲ +199.6 pp |
| 2024 | -406.2% | €-474.49 Million | €116.81 Million | €591.30 Million | ▼ -396.1 pp |
| 2023 | -10.1% | €-39.79 Million | €395.36 Million | €435.15 Million | ▼ -54.0 pp |
| 2022 | 44.0% | €308.56 Million | €702.04 Million | €393.49 Million | ▼ -33.7 pp |
| 2021 | 77.7% | €693.39 Million | €892.52 Million | €199.13 Million | — |